Get startedLog in
    Picture of Intelgenx Technologies logo

    IGX — Intelgenx Technologies News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Intelgenx Receives Positive DSMB Recommendation For Montelukast VersaFilm Phase 2A Trial

    Picture of Intelgenx Technologies logoIntelgenx Technologies
    09/10/2019 13:13
    Oct 9 (Reuters) - Intelgenx Technologies Corp  IGX.V :
    * INTELGENX RECEIVES POSITIVE DSMB RECOMMENDATION FOR
MONTELUKAST
VERSAFILM® PHASE 2A TRIAL
    * INTELGENX TECHNOLOGIES CORP - WITH NO SAFETY CONCERNS,
DSMB
RECOMMENDS TRIAL CONTINUES; DOSE INCREASE PLANNED
    * INTELGENX TECHNOLOGIES CORP - DSMB DID NOT RAISE ANY
CONCERNS
REGARDING SAFETY AND RECOMMENDED THAT TRIAL CONTINUE.

Source text for Eikon:  ID:nGNXb9L0HY 
Further company coverage:  IGX.V 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Intelgenx Technologies

    See all news